Literature DB >> 3978628

Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells.

J Moan, S Sommer.   

Abstract

Cells of the established line NHIK 3025 were incubated with hematoporphyrin derivative and exposed to light at different concentrations of oxygen. The efficiency of photoinactivation of the sensitized cells decreased with decreasing oxygen concentration. No photoinactivation was observed when the atmosphere above the medium overlying the cells was pure N2 gas. With 1% O2 in the atmosphere, the quantum yield of photoinactivation was reduced by 50% compared to the yield in air-saturated medium. It is hardly possible to inactivate cells in anoxic regions of a tumor by means of porphyrin sensitized photochemotherapy. In spite of this, the therapy seems to be efficient in several cases. Thus, it seems that anoxic tumor cells are inactivated in secondary reactions, probably due to breakdown of the circulatory system in the tumor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978628

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy.

Authors:  G H Raab; A F Schneider; W Eiermann; H Gottschalk-Deponte; R Baumgartner; W Beyer
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

Review 2.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

3.  Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy.

Authors:  Kishore R Rollakanti; Stephen C Kanick; Scott C Davis; Brian W Pogue; Edward V Maytin
Journal:  Photonics Lasers Med       Date:  2013-11-01

4.  Effects of the oxygenation level on formation of different reactive oxygen species during photodynamic therapy.

Authors:  Michael Price; Lance Heilbrun; David Kessel
Journal:  Photochem Photobiol       Date:  2013-01-25       Impact factor: 3.421

Review 5.  Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer.

Authors:  Petras Juzenas; Wei Chen; Ya-Ping Sun; Manuel Alvaro Neto Coelho; Roman Generalov; Natalia Generalova; Ingeborg Lie Christensen
Journal:  Adv Drug Deliv Rev       Date:  2008-09-20       Impact factor: 15.470

6.  Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.

Authors:  E Blake; J Allen; C Thorn; A Shore; A Curnow
Journal:  Lasers Med Sci       Date:  2012-08-28       Impact factor: 3.161

7.  Neuronal injury after photoactivation of photofrin II.

Authors:  Y Yoshida; M O Dereski; J H Garcia; F W Hetzel; M Chopp
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

Review 8.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

Review 9.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

10.  Effects of zinc porphyrin and zinc phthalocyanine derivatives in photodynamic anticancer therapy under different partial pressures of oxygen in vitro.

Authors:  Martin Pola; Hana Kolarova; Jiri Ruzicka; Aleksey Zholobenko; Martin Modriansky; Jiri Mosinger; Robert Bajgar
Journal:  Invest New Drugs       Date:  2020-08-24       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.